Alx Oncology Holdings
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +10.2% | -12.3% | +0.9% | -13.5% | -20.4% | -18.2% | -21.2% | -13.2% | -28.6% | +202.0% | -9.8% | |
| – | -5.2% | -11.0% | +0.5% | -7.6% | -13.8% | -23.7% | -16.8% | -22.0% | -23.7% | +187.0% | -1.4% | |
| – | +14.4% | -37.3% | +10.6% | +3.7% | +9.1% | +17.3% | -6.4% | +21.4% | -30.2% | +97.2% | -29.7% | |
| – | -3.8% | -13.8% | -0.5% | -5.2% | -14.0% | -23.4% | -18.9% | -23.6% | -26.1% | +213.3% | -1.5% | |
| – | +66.7% | +10.0% | +467.3% | -81.0% | -24.6% | +2.1% | -26.9% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2.9% | -8.3% | +14.1% | -11.6% | -30.2% | -4.5% | -5.2% | +22.7% | -12.8% | -18.4% | -8.7% | |
| – | +2.4% | -10.5% | +19.3% | -15.9% | -42.8% | +1.3% | +0.6% | +47.1% | -11.4% | -17.8% | -26.8% | |
| – | -4.3% | +13.4% | -2.4% | – | – | +299.8% | +190.4% | -13.9% | +20.0% | +0.0% | – | |
| – | -33.9% | -27.5% | +30.8% | -3.1% | -43.0% | -12.5% | +24.5% | +34.3% | -25.4% | -21.6% | -21.6% | |
| – | +0.7% | +0.7% | +0.7% | +0.7% | -3.7% | -13.1% | -15.0% | -17.6% | -21.4% | -27.3% | +194.5% | |
| – | +12.4% | -13.5% | -3.0% | -14.1% | -17.0% | -22.3% | -27.0% | -30.5% | -42.0% | +482.5% | -10.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +19.1% | +2.3% | +3.4% | +1.7% | +0.2% | +1.1% | +0.2% | +0.2% | +1.3% | +92.6% | +29.7% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.